Cambrex Corp (CBM) Return on Investment ROI from the third quarter of 2019 to third quarter of 2018 and for the year 2019, average high and low, overall ranking from Sep 30 2019 to Sep 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cambrex Corp  (CBM)


Cambrex's ROI from its third quarter of 2019 to the third quarter of 2018 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cambrex's ROI in the third quarter of 2019?
Cambrex Corp achieved a return on average invested assets (ROI) of 2.85 % in its third quarter of 2019, which is below Cambrex's average return on investment, which stands at 14.19%.

ROI decreased relative to the period ending Jun 30 2019, due to the decline in net income.

Within the Healthcare sector 167 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2019 from 1105 to 1845.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Investment Change TTM 58.9 % 84.05 % 70.71 % 54.79 % 44.08 %
Y / Y Net Income Change TTM -72.02 % -55.78 % -3.48 % 60.57 % 660.09 %
Investment (TTM) in Millions 1,335 1,352 1,363 1,119 1,156
Return On Investment (TTM) 2.85 % 4.33 % 7.21 % 9.95 % 16.17 %
CBM's Overall Ranking # 1845 # 1105 # 0 # 982 # 532
Seq. Investment Change TTM 3.59 % 14.11 % 17.73 % 14.17 % 19.99 %
Seq. Net Income Change TTM -31.84 % -31.49 % -14.77 % -29.7 % 7.73 %
Net Income (TTM) in Millions 37 54 79 92 131

CBM Company Profile >> Back to CBM Roi Comparisons >> See Annual CBM Return On Investment



Return On Investment CBM's Ranking
Within: No.
Industry # 60
Sector # 168
Overall # 1845

Return On Investment Statistics
High Average Low
19.34 %
14.19 %
2.85 %
  (Sep 30 2019)







Financial Statements
Cambrex's III. Quarter Investments $ 1,335 Millions CBM's Balance sheet
Cambrex's III. Quarter Income $ 10 Millions Quarterly CBM's Income Statement
CBM's Income by Division See CBM's Income by Division


CBM Annual Return On Investment (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 1,119 658 516 376 388
Y / Y Investment Growth 70.06 % 27.42 % 37.44 % -3.23 % 7.63 %
Net Income in Millions 92 102 82 57 57
Y / Y Net Income Growth -9.79 % 25.43 % 42.75 % -0.15 % 121.12 %
Annual Return On Investment 8.26 % 15.57 % 15.82 % 15.23 % 14.76 %


Annual Roi Comment
In the fiscal year 2018 ROI decreased relative to the previous year to 8.26 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CBM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CBM's Competitors
Subscribers only: Roi for Cambrex's Suppliers
Subscribers only: Return On Investment for CBM's Customers

Other Ratios
CBM's Roa CBM's Inventory Turnover Ratio CBM's Growth Rates CBM's Dividend Statistics
CBM's Profitability Ratios CBM's Asset Turnover Ratio CBM's Dividend Growth
CBM's Roe CBM's Valuation Ratios CBM's Financial Strength Ratios CBM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2019, within Healthcare Sector ROI
Abbvie Inc   7.79 %
Teleflex Incorporated  7.72 %
Cnbx Pharmaceuticals Inc   7.42 %
Universal Health Services Inc   7.42 %
Hca Healthcare Inc   7.01 %
Phibro Animal Health Corporation  7.01 %
National Healthcare Corp  6.67 %
Ensign Group Inc  6.66 %
Heartbeam Inc   6.56 %
Denali Therapeutics Inc   6.47 %
Steris Plc  6.46 %
Charles River Laboratories International inc   6.40 %
Lhc Group Inc   6.33 %
Lifeloc Technologies Inc   6.12 %
Cryo cell International Inc   6.11 %
Boston Scientific Corporation  6.02 %
Xencor Inc  5.96 %
Ani Pharmaceuticals Inc  5.95 %
Bio rad Laboratories Inc   5.90 %
Staar Surgical Co  5.76 %
Medtronic Plc  5.72 %
Surmodics Inc   5.69 %
Abbott Laboratories  5.61 %
Bio techne Corp  5.39 %
Icu Medical Inc  5.35 %
Addus Homecare Corp  5.30 %
Gilead Sciences Inc   5.18 %
Kyntra Bio Inc   5.01 %
Integer Holdings Corporation  4.80 %
Envista Holdings Corporation  4.63 %

Date modified: 2026-09-08T15:09:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.